NCNO
nCino, Inc.
NCNO's outlook is improving, though it still trails on the overall score.
PLTR
Palantir Technologies Inc.
PLTR has the edge over NCNO overall, supported by stronger valuation and stronger modeled upside.
NCNO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Stable |
NCNO's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
NCNO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $22.36 | — |
| Cheap | 72x | $21.56 | -3.6% |
| Current | 75x | $22.36 | — |
| Fair | 133x | $40.02 | +79% |
| Expensive | 333x | $99.88 | +347% |
Historical ranges are pointers, not guarantees.
NCNO's PE is 75x, but its earnings don't support one, so it isn't a reliable read right now.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over NCNO in the historical PE scenario, which offers more potential upside but is not a forecast.
NCNO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for NCNO, with profitability improving.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for PLTR, with profitability improving.
NCNO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.51 | +405% |
| Q3 2026 | $0.30 | +$0.58 |
| Q2 2026 | $0.12 | +$0.37 |
| Q1 2026 | $0.05 | +$0.38 |
| Q4 2025 | -$0.17 | $0.00 |
| Q3 2025 | -$0.28 | -$0.01 |
| Q2 2025 | -$0.25 | +$0.06 |
| Q1 2025 | -$0.33 | +$0.05 |
| Q4 2024 | -$0.17 | +$0.41 |
NCNO has returned to profit: it earned $0.30 per share over the past year, after losing money the year before.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over NCNO on earnings, with more consistent year-over-year improvement.
NCNO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $161M | +8.2% |
| Q2 2026 | $159.4M | +11% |
| Q1 2026 | $149.7M | +5.9% |
| Q4 2025 | $152.2M | +9.6% |
| Q3 2025 | $148.8M | +12% |
| Q2 2025 | $144.1M | +13% |
| Q1 2025 | $141.4M | +14% |
| Q4 2024 | $138.8M | +14% |
NCNO's revenue has grown year over year every quarter since late 2020: $161M last quarter, up 8.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.5% | +15 points |
| Q2 2026 | 13% | +14 points |
| Q1 2026 | 1.9% | +5.9 points |
| Q4 2025 | 7.7% | +8.3 points |
| Q3 2025 | -6.3% | -0.3 points |
| Q2 2025 | -1.1% | +1.8 points |
| Q1 2025 | -4.1% | -1.5 points |
| Q4 2024 | -0.6% | +10 points |
NCNO's operating margin was 8.5% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over NCNO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over NCNO on profitability, with a higher operating margin.
NCNO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $34M | +170% |
| Q2 2026 | $80.8M | +54% |
| Q1 2026 | $12.5M | +$22.8M |
| Q4 2025 | $4.9M | -3.9% |
| Q3 2025 | $12.6M | +176% |
| Q2 2025 | $52.6M | -2.8% |
| Q1 2025 | -$10.4M | -234% |
| Q4 2024 | $5.1M | -2.9% |
NCNO generated $132M in free cash flow over the past year, up 121% from the year before.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over NCNO on cash flow, with more consistent year-over-year improvement.
NCNO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.7% | -4.1M shares |
| 1 year | -8.6% | -9.9M shares |
| 3 years | -6.3% | -7M shares |
| 5 years | +10% | +9.7M shares |
| Available history | +18% | +15.7M shares |
NCNO has the edge over PLTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $65.6M |
| Q2 2026 | $110.1M |
| Q1 2026 | $25M |
| Q4 2025 | $39.5M |
| Q3 2025 | $20M |
| Q2 2025 | $40.6M |
| Q1 2022 | — |
| Q4 2021 | — |
NCNO spent $240M buying back its own shares over the past year.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
NCNO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 3.1x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.3x | Elevated |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | -5.0x | Net Cash |
NCNO's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has the edge over NCNO on leverage, with a lower net debt burden relative to earnings.
NCNO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.1 | Neutral |
| Stochastic | 77.0 | Neutral |
NCNO's weekly RSI is 58 (neutral) and its Stochastic is 77 (neutral).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
NCNO PE vs Technology Sector
| Metric | NCNO | Sector median | Relative |
|---|---|---|---|
| PE | 75x | 28x | 168% above |
| PE % | 19 | 37 | 18 pts below |
NCNO has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
NCNO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 5.7% above |
| 20 week MA | $20.3 | 10% above |
| 50 week MA | $19.4 | 15% above |
| 100 week MA | $23.8 | 6.2% below |
| 200 week MA | $27.2 | 18% below |
NCNO has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 18% below its 200-week average.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR has the edge over NCNO on trend strength, trading above more of its moving averages.
NCNO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $74.0 | $78.7 | +6.3% |
| 2021 | $78.7 | $57.0 | -28% |
| 2022 | $57.0 | $25.9 | -55% |
| 2023 | $25.9 | $33.6 | +30% |
| 2024 | $33.6 | $34.4 | +2.4% |
| 2025 | $34.4 | $26.3 | -24% |
| 2026 YTD | $26.3 | $22.4 | -15% |
NCNO has finished lower in three of the last six years. It's down 15% so far in 2026.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR has the edge over NCNO on returns for 2026, with the stronger performance.